Effect of azacytidine administration with/without folic acid on the histology and genomic DNA methylation of mice liver
Northern Technical University/ Technical College of Kirkuk Medical Laboratory Technique Department.
Research Article
GSC Biological and Pharmaceutical Sciences, 2020, 11(02), 196-203.
Article DOI: 10.30574/gscbps.2020.11.2.0132
Publication history:
Received on 07 May 2020; revised on 20 May 2020; accepted on 21 May 2020
Abstract:
Azacitidine is a cytosine analog and antineoplastic agent used in the therapy of myelodysplastic syndromes with mild to moderate liver injuries. Accordingly, this research implicated to evaluate the epigenetic effect of azacytidine on mice liver as a model organism and to determine the role of folic acid administration as a protective methyl donor micronutrient. Thus, forty-eight mice were divided into four groups, reliant on the kind of treatment they received, where animals received calculated doses of azacytidine and folic acid twice a week for three months. Then, animals were killed, and their livers were autopsied and examined for histopathological abnormalities, followed by a genetic assessment for the DNA banding pattern profile of the excised livers. It was found that the anticancer drug azacytidine processes a hepatotoxic effect, and it profoundly modifies the DNA banding pattern. While the combination of folic acid with the administration of azacytidine might induce a protective effect against azacytidine toxic effects, these findings might unravel essential insights and highlight new potential cancer therapeutics.
Keywords:
Azacytidine; Folic acid; Histology; Genomic DNA; Mice liver; RAPD-PCR
Full text article in PDF:
Copyright information:
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
